Fitxa

oai_dc

Descarregar XML

<?xml version="1.0" encoding="UTF-8" ?>

1. <oai_dc:dc schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">

   1. <dc:title>A glimpse into relapsed refractory multiple myeloma treatment in real-world practice in Spain: the GeminiS study</dc:title>

   2. <dc:creator>Ríos-Tamayo, Rafael</dc:creator>

   3. <dc:creator>Soler, Juan Alfons</dc:creator>

   4. <dc:creator>García-Sánchez, Ricarda</dc:creator>

   5. <dc:creator>Pérez Persona, Ernesto</dc:creator>

   6. <dc:creator>Arnao, Mario</dc:creator>

   7. <dc:creator>García-Guiñón, Antoni</dc:creator>

   8. <dc:creator>Domingo, Abel</dc:creator>

   9. <dc:creator>González-Pardo, Miriam</dc:creator>

   10. <dc:creator>de la Rubia Comos, Javier</dc:creator>

   11. <dc:creator>Mateos, Maria-Victoria</dc:creator>

   12. <dc:creator>GeminiS Study Investigators</dc:creator>

   13. <dc:subject>Relapsed-refractory multiple myeloma</dc:subject>

   14. <dc:subject>Real-world</dc:subject>

   15. <dc:subject>Monoclonal antibodies</dc:subject>

   16. <dc:subject>Daratumumab</dc:subject>

   17. <dc:subject>Standard of care</dc:subject>

   18. <dc:subject>32 Ciencias Médicas</dc:subject>

   19. <dc:description>The aim of this study is to describe the incorporation of monoclonal antibodies (mAb) in real-world (RW) practice for the treatment of patients with relapsed refractory multiple myeloma (RRMM) in a setting with other treatment alternatives.</dc:description>

   20. <dc:description>This study was sponsored by Janssen-Cilag. Janssen-Cilag participated in the study design, data analysis and drafting of the manuscript. All investigators received financial com- pensation for their participation in the study.</dc:description>

   21. <dc:description>Medicina</dc:description>

   22. <dc:date>2024-06-25T11:40:20Z</dc:date>

   23. <dc:date>2024-06-25T11:40:20Z</dc:date>

   24. <dc:date>2023-02</dc:date>

   25. <dc:type>article</dc:type>

   26. <dc:identifier>http://hdl.handle.net/20.500.12466/4403</dc:identifier>

   27. <dc:identifier>10.1080/16078454.2023.2178997</dc:identifier>

   28. <dc:identifier>1607-8454</dc:identifier>

   29. <dc:language>eng</dc:language>

   30. <dc:rights>Atribución 4.0 Internacional</dc:rights>

   31. <dc:rights>http://creativecommons.org/licenses/by/4.0/</dc:rights>

   32. <dc:rights>openAccess</dc:rights>

   </oai_dc:dc>

edm

Descarregar XML

<?xml version="1.0" encoding="UTF-8" ?>

1. <rdf:RDF schemaLocation="http://www.w3.org/1999/02/22-rdf-syntax-ns# http://www.europeana.eu/schemas/edm/EDM.xsd">

   1. <edm:ProvidedCHO about="http://hdl.handle.net/20.500.12466/4403">

      1. <dc:creator>Ríos-Tamayo, Rafael</dc:creator>

      2. <dc:creator>Soler, Juan Alfons</dc:creator>

      3. <dc:creator>García-Sánchez, Ricarda</dc:creator>

      4. <dc:creator>Pérez Persona, Ernesto</dc:creator>

      5. <dc:creator>Arnao, Mario</dc:creator>

      6. <dc:creator>García-Guiñón, Antoni</dc:creator>

      7. <dc:creator>Domingo, Abel</dc:creator>

      8. <dc:creator>González-Pardo, Miriam</dc:creator>

      9. <dc:creator>de la Rubia Comos, Javier</dc:creator>

      10. <dc:creator>Mateos, Maria-Victoria</dc:creator>

      11. <dc:creator>GeminiS Study Investigators</dc:creator>

      12. <dc:date>2023-02</dc:date>

      13. <dc:description>The aim of this study is to describe the incorporation of monoclonal antibodies (mAb) in real-world (RW) practice for the treatment of patients with relapsed refractory multiple myeloma (RRMM) in a setting with other treatment alternatives.</dc:description>

      14. <dc:identifier>http://hdl.handle.net/20.500.12466/4403</dc:identifier>

      15. <dc:language>eng</dc:language>

      16. <dc:subject>Relapsed-refractory multiple myeloma</dc:subject>

      17. <dc:subject>Real-world</dc:subject>

      18. <dc:subject>Monoclonal antibodies</dc:subject>

      19. <dc:subject>Daratumumab</dc:subject>

      20. <dc:subject>Standard of care</dc:subject>

      21. <dc:subject>32 Ciencias Médicas</dc:subject>

      22. <dc:title>A glimpse into relapsed refractory multiple myeloma treatment in real-world practice in Spain: the GeminiS study</dc:title>

      23. <dc:type>article</dc:type>

      24. <edm:type>TEXT</edm:type>

      </edm:ProvidedCHO>

   2. <ore:Aggregation about="http://hdl.handle.net/20.500.12466/4403#aggregation">

      1. <edm:aggregatedCHO resource="http://hdl.handle.net/20.500.12466/4403" />

      2. <edm:dataProvider>Repositorio Institucional de la Universidad Católica de Valencia San Vicente Mártir</edm:dataProvider>

      3. <edm:isShownAt resource="http://hdl.handle.net/20.500.12466/4403" />
      4. <edm:isShownBy resource="https://riucv.ucv.es/bitstream/20.500.12466/4403/1/A%20glimpse%20into%20relapsed%20refractory%20multiple%20myeloma%20treatment%20in%20real-world%20practice%20in%20Spain%20the%20GeminiS%20study.pdf" />
      5. <edm:object resource="https://riucv.ucv.es/bitstream/20.500.12466/4403/4/A%20glimpse%20into%20relapsed%20refractory%20multiple%20myeloma%20treatment%20in%20real-world%20practice%20in%20Spain%20the%20GeminiS%20study.pdf.jpg" />

      6. <edm:provider>Hispana</edm:provider>

      7. <edm:rights resource="http://creativecommons.org/licenses/by/4.0/" />

      </ore:Aggregation>

   3. <edm:WebResource about="https://riucv.ucv.es/bitstream/20.500.12466/4403/1/A%20glimpse%20into%20relapsed%20refractory%20multiple%20myeloma%20treatment%20in%20real-world%20practice%20in%20Spain%20the%20GeminiS%20study.pdf">

      1. <edm:rights resource="http://creativecommons.org/licenses/by/4.0/" />

      </edm:WebResource>

   </rdf:RDF>